BioMarin Pharmaceutical, Inc. (BMRN)
55.95
-0.68
(-1.20%)
USD |
NASDAQ |
Oct 23, 16:00
55.96
+0.01
(+0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical Max Drawdown (5Y) : 58.73% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 58.73% |
| August 31, 2026 | 58.73% |
| July 31, 2026 | 58.73% |
| June 30, 2026 | 58.73% |
| May 31, 2026 | 58.73% |
| April 30, 2026 | 58.73% |
| March 31, 2026 | 58.73% |
| February 28, 2026 | 58.73% |
| January 31, 2026 | 58.73% |
| December 31, 2025 | 58.73% |
| November 30, 2025 | 58.73% |
| October 31, 2025 | 58.73% |
| September 30, 2025 | 58.73% |
| August 31, 2025 | 58.73% |
| July 31, 2025 | 58.73% |
| June 30, 2025 | 58.73% |
| May 31, 2025 | 57.35% |
| April 30, 2025 | 57.35% |
| March 31, 2025 | 53.26% |
| February 28, 2025 | 53.26% |
| January 31, 2025 | 53.26% |
| December 31, 2024 | 52.74% |
| November 30, 2024 | 52.74% |
| October 31, 2024 | 52.14% |
| September 30, 2024 | 56.53% |
| Date | Value |
|---|---|
| August 31, 2024 | 56.90% |
| July 31, 2024 | 56.90% |
| June 30, 2024 | 56.90% |
| May 31, 2024 | 56.90% |
| April 30, 2024 | 56.90% |
| March 31, 2024 | 56.90% |
| February 29, 2024 | 56.90% |
| January 31, 2024 | 56.90% |
| December 31, 2023 | 56.90% |
| November 30, 2023 | 56.90% |
| October 31, 2023 | 56.90% |
| September 30, 2023 | 56.90% |
| August 31, 2023 | 56.90% |
| July 31, 2023 | 56.90% |
| June 30, 2023 | 56.90% |
| May 31, 2023 | 56.90% |
| April 30, 2023 | 56.90% |
| March 31, 2023 | 56.90% |
| February 28, 2023 | 56.90% |
| January 31, 2023 | 56.90% |
| December 31, 2022 | 56.90% |
| November 30, 2022 | 56.90% |
| October 31, 2022 | 56.90% |
| September 30, 2022 | 56.90% |
| August 31, 2022 | 56.90% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ascendis Pharma A/S | 61.72% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
| Cytokinetics, Inc. | 72.39% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -10.89 |
| Beta (5Y) | 0.2168 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 28.52% |
| Historical Sharpe Ratio (5Y) | -0.3059 |
| Historical Sortino (5Y) | -0.5113 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 13.50% |